| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/1996 | US5536747 Enzyme inhibitors |
| 07/16/1996 | US5536745 (Hetero)-aryl ketones derivatives with antibacterial properties |
| 07/16/1996 | US5536744 Dilation of blood vessels |
| 07/16/1996 | US5536743 Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
| 07/16/1996 | US5536742 Anti-seborrhoeic formulation |
| 07/16/1996 | US5536740 Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester |
| 07/16/1996 | US5536739 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
| 07/16/1996 | US5536738 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
| 07/16/1996 | US5536736 Triazolyl-phenoxyacetic acid compounds which have useful pharmaceutical utility |
| 07/16/1996 | US5536735 Pharmaceutical composition |
| 07/16/1996 | US5536733 Gastrointestinal |
| 07/16/1996 | US5536730 Imidazonaphthyridine derivatives |
| 07/16/1996 | US5536729 Rapamycin formulations for oral administration |
| 07/16/1996 | US5536727 Treatment of hyperandrogenic diseases |
| 07/16/1996 | US5536722 Triazine derivatives for enhancing antitumor activity |
| 07/16/1996 | US5536721 Thieno[2,3-b-indole derivatives and their use for treating central nervous system diseases related to the metabotropic glutamate receptor system |
| 07/16/1996 | US5536719 Nervous system disorders |
| 07/16/1996 | US5536718 Tricyclic benzazepine vasopressin antagonists |
| 07/16/1996 | US5536715 Combinations of anthelmintically active agents |
| 07/16/1996 | US5536714 Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses |
| 07/16/1996 | US5536713 Osteoporosis |
| 07/16/1996 | US5536709 2(1H)-quinolone compounds |
| 07/16/1996 | US5536508 Biodegradable polymer and polysaccharide gel and bioadhesive with drug |
| 07/16/1996 | US5536504 Ultramicroemulsions from spontaneously dispersible concentrates containing xanthophyll esters and having antitumor activity |
| 07/16/1996 | US5536503 Lobeline |
| 07/16/1996 | US5536500 Monoesters and diesters of cinnamic acid or of one of the derivatives thereof and of vitamin c, process for the preparation thereof, and use as antioxidants in cosmetic, pharmaceutical or nutritional compositions |
| 07/16/1996 | US5536469 System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system |
| 07/16/1996 | US5536241 Methods and devices for relaxing smooth muscle contractions |
| 07/16/1996 | US5535760 Method for detecting and treating Alzheimer's disease |
| 07/16/1996 | CA2085520C Stable hexahydrate of etoposide 4'-phosphate disodium salt |
| 07/16/1996 | CA2029616C Chemical compound exhibiting anti-bacterial and anti-tumour activity |
| 07/16/1996 | CA2021338C Imidazoquinolone derivatives |
| 07/16/1996 | CA2014520C Hexitol derivatives |
| 07/13/1996 | CA2166958A1 Indolepiperidine derivatives |
| 07/12/1996 | CA2166854A1 3-alkoxycarbonyl-thiadiazinones |
| 07/11/1996 | WO1996021037A1 Arachidonic acid and methods for the production and use thereof |
| 07/11/1996 | WO1996020949A1 Peptide and peptide analog protease inhibitors |
| 07/11/1996 | WO1996020948A1 Human pak65 |
| 07/11/1996 | WO1996020945A1 Novel aminooligosaccharide derivative and process for preparing the same |
| 07/11/1996 | WO1996020941A1 Hydroxymethylimidazodiazepines and their esters |
| 07/11/1996 | WO1996020939A1 POLYMORPHS B AND C OF 1-[2,4-DICHLORO-β-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE |
| 07/11/1996 | WO1996020937A1 Acetylenes disubstituted with hydroxyaryl and aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | WO1996020936A1 Novel thiazolidin-4-one derivatives |
| 07/11/1996 | WO1996020934A1 Process for the preparation of lamotrigine |
| 07/11/1996 | WO1996020930A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | WO1996020929A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
| 07/11/1996 | WO1996020927A1 DIBENZ[cd,f]INDOLE DERIVATIVES |
| 07/11/1996 | WO1996020926A1 Substituted imides as tnf inhibitors |
| 07/11/1996 | WO1996020922A1 Novel carbamate compounds containing thiocarbamoyl group and process for preparing the same |
| 07/11/1996 | WO1996020918A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | WO1996020915A1 Novel immunotherapeutic aryl amides |
| 07/11/1996 | WO1996020914A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | WO1996020913A1 Novel trienoic retinoid compounds and methods |
| 07/11/1996 | WO1996020728A1 Antitumor agent potentiator comprising il-6 antagonist |
| 07/11/1996 | WO1996020719A2 Body fluid replacement solution |
| 07/11/1996 | WO1996020718A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 07/11/1996 | WO1996020717A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | WO1996020715A1 The use of inositoltrisphosphate for the preparing of medicaments |
| 07/11/1996 | WO1996020714A1 Antifungal agent containing crotamiton, and salicyclic aldehyde |
| 07/11/1996 | WO1996020713A1 Treatment of hyperandrogenic conditions |
| 07/11/1996 | WO1996020711A1 Drugs to prevent recurrent herpes virus infections |
| 07/11/1996 | WO1996020710A1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/11/1996 | WO1996020709A1 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals |
| 07/11/1996 | WO1996020708A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 07/11/1996 | WO1996020707A1 Pharmaceutical preparations containing nifedipine and process for producing it |
| 07/11/1996 | WO1996020706A1 Thrombolytic agent |
| 07/11/1996 | WO1996020705A1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNF$g(a) |
| 07/11/1996 | WO1996020704A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 07/11/1996 | WO1996020703A1 Compounds for veterinary and medicinal applications |
| 07/11/1996 | WO1996020702A1 The use of 2,3-alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome |
| 07/11/1996 | WO1996020701A1 Apoptosis-modulating composition comprising a factor affecting the intracellular rate of methional or malondialdehyde |
| 07/11/1996 | WO1996020700A1 Pharmacologic management of snoring |
| 07/11/1996 | WO1996020699A1 Composition and methods for transdermal delivery of acid-labile drugs |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | WO1996020697A1 Terfenadine oral granules |
| 07/11/1996 | WO1996020690A2 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 07/11/1996 | WO1996020600A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
| 07/11/1996 | WO1996020599A1 Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
| 07/11/1996 | WO1996015128A3 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 07/11/1996 | WO1996012508A3 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 07/11/1996 | WO1996012498A3 Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation |
| 07/11/1996 | CA2209663A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | CA2209619A1 Thrombolytic agents |
| 07/11/1996 | CA2209424A1 Hydroxymethylimidazodiazepines and their esters |
| 07/11/1996 | CA2209276A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 07/11/1996 | CA2209234A1 Peptide and peptide analog protease inhibitors |
| 07/11/1996 | CA2209228A1 Novel carbamate compounds containing thiocarbamoyl group and process forpreparing the same |
| 07/11/1996 | CA2209134A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | CA2208986A1 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals |
| 07/11/1996 | CA2208844A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | CA2208687A1 Treatment of hyperandrogenic conditions |
| 07/11/1996 | CA2208679A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | CA2208580A1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2206519A1 Dibenz¬cd,f|indole derivatives |
| 07/11/1996 | CA2184174A1 Novel thiazolidin-4-one derivatives |
| 07/10/1996 | EP0720988A1 Pseudopeptides containing trifluoromethyl substituted 2-azabicyclooctane |
| 07/10/1996 | EP0720986A1 Platinum complex and malignant tumor treating drug containing the same |
| 07/10/1996 | EP0720982A1 Benzimidazole derivatives, their production and use and use as angiotensin II antagonists |
| 07/10/1996 | EP0720857A1 Syringe |